Case Control Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Feb 15, 2024; 16(2): 343-353
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.343
Table 4 Uni- and multi-variate analyses of factors associated with 3-year replase-free survival rates in patients with colorectal cancer
VariableUnivariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
Age (yr)≥ 65/< 651.6250.781-3.3800.194
SexFemale/male1.5030.724-3.1180.274
BMI (kg/m2)≥ 24/ < 240.3540.135-0.9280.0350.7920.269-2.3370.673
Tumor siteColon/rectum0.9860.469-2.0740.970
ComorbiditiesYes/no1.4620.624-3.4280.382
SarcopeniaYes/no6.7953.240-14.250< 0.014.1221.678-10.1250.002
WBC (× 109/L)≥ 10/< 101.7280.410-7.2830.490
Platelet (× 109/L)≥ 300/< 3001.2940.392-4.2760.673
Hemoglobin (g/L)≥ 90/< 900.4920.199-1.2140.124
CRP (mg/L)> 10/≤ 101.6250.491-5.3820.427
CEA (ng/mL)≥ 3.4/< 3.42.3561.072-5.1770.0332.2200.989-4.9840.053
CA199 (U/mL)≥ 37/< 371.4830.352-6.2430.591
Postoperative complicationsYes/no1.0280.300-3.5290.965
TNM stageⅢ/Ⅰ,Ⅱ3.4771.581-7.6500.0023.6031.612-8.0530.002
CONUT score≥ 5/≤ 44.7242.177-10.254< 0.012.9921.241-7.2120.015